Evonik Evonik

X

Find Radio Compass News for Temsirolimus

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207383

FDA
20 Aug 2019

https://www.fiercebiotech.com/biotech/az-drops-mid-stage-cancer-drug-vistusertib

Phil Taylor FIERCE BIOTECH
08 Nov 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207383

FDA
29 Oct 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203153

FDA
01 Aug 2018

https://www.forbes.com/sites/greatspeculations/2017/12/14/pfizers-bet-on-oncology/#4051a9d65f56

FORBES
14 Dec 2017

http://www.thehindubusinessline.com/companies/article9547318.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication

AESHA DATTA THE HINDU BUSINESS LINE
16 Feb 2017

http://www.prnewswire.com/news-releases/novartis-drug-afinitor-significantly-reduces-seizures-in-phase-iii-study-of-patients-with-tuberous-sclerosis-complex-300254627.html

PR NEWS WIRE
21 Apr 2016

http://www.tax-news.com/news/Brazil_Reduces_Duty_On_Specific_Pharmaceuticals____70067.html

Mike Godfrey TAX-NEWS
02 Jan 2016
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY